USANA Health Sciences (NYSE: USNA) reported Q1 EPS of $0.61, $0.21 better than the analyst estimate of $0.40. Revenue for the quarter came in at $250 million versus the consensus estimate of $240.95 million.
Company reiterates fiscal 2026 guidance.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.